XML 43 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Net income (loss) $ (86,839) $ (162,261)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 4,298 2,492
Stock-based compensation 21,853 18,573
Amortization of convertible senior notes discount and debt issuance costs 6,300 5,581
Amortization of finite-lived intangible assets 10,441  
Changes in fair value of liability for contingent consideration 5,952 56,392
Non-cash milestone payment received   (1,462)
Realized losses on sale of marketable securities 94  
Changes in operating assets and liabilities:    
Accounts receivable (52,194)  
Receivable from collaboration partners (11,981) (3,780)
Inventory (14,205)  
Prepaid expenses and other current assets 10,631 25
Other assets (817) (3,029)
Accounts payable 2,558 84
Accrued liabilities (3,927) (10,119)
Accrued clinical trials and related expenses (1,825) 5,886
Accrued compensation (7,084) (3,190)
Deferred revenue 216  
Lease termination exit costs liability   (3,177)
Other current liabilities 1,044  
Other liabilities 961 11,008
Net cash (used in) provided by operating activities (114,524) (86,977)
Cash flows from investing activities:    
Purchases of marketable securities (276,270) (124,070)
Sales of marketable securities 16,182 104,764
Maturities of marketable securities 165,956 131,516
Capital expenditures (10,696) (16,063)
Net cash (used in) provided by investing activities (104,828) 96,147
Cash flows from financing activities:    
Repurchases of restricted stock awards (417) (124)
Net proceeds from issuances of common stock 389,602 25,608
Payment for redemption of convertible senior notes (9)  
Net cash provided by financing activities 389,176 25,484
Net increase (decrease) in cash and cash equivalents 169,824 34,654
Cash and cash equivalents at beginning of period 153,244 171,552
Cash and cash equivalents at end of period 323,068 206,206
Supplemental cash flow data    
Cash paid during the period for income taxes 34 42
Cash paid during the period for interest $ 4,600 $ 4,600